Technical Analysis for ZNTL - Zentalis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 32.9 0.27% 0.09
ZNTL closed up 0.27 percent on Friday, August 14, 2020, on 20 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical ZNTL trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 0.27%
Stochastic Buy Signal Bullish 0.27%
Wide Bands Range Expansion 0.27%
Oversold Stochastic Weakness 0.27%
Wide Bands Range Expansion 1.04%
Down 3 Days in a Row Weakness 1.04%
Oversold Stochastic Weakness 1.04%
Outside Day Range Expansion -2.84%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zentalis Pharmaceuticals LLC is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin Bunker on December 23, 2014 and is headquartered in New York, NY.
Biopharmaceutical Cancer Drugs Hormones Tyrosine Kinase Receptors Epidermal Growth Factor Receptor Her2/Neu Metastatic Breast Cancer Antiestrogens Selective Estrogen Receptor Degraders

Is ZNTL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.32
52 Week Low 23.25
Average Volume 219,125
200-Day Moving Average 0.00
50-Day Moving Average 42.23
20-Day Moving Average 36.61
10-Day Moving Average 34.08
Average True Range 2.62
ADX 24.24
+DI 10.80
-DI 25.04
Chandelier Exit (Long, 3 ATRs ) 37.06
Chandelier Exit (Short, 3 ATRs ) 38.96
Upper Bollinger Band 43.24
Lower Bollinger Band 29.97
Percent B (%b) 0.22
BandWidth 36.24
MACD Line -2.57
MACD Signal Line -2.44
MACD Histogram -0.125
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.44
Resistance 3 (R3) 35.50 34.71 35.01
Resistance 2 (R2) 34.71 34.07 34.68 34.87
Resistance 1 (R1) 33.81 33.67 34.26 33.75 34.73
Pivot Point 33.02 33.02 33.25 32.99 33.02
Support 1 (S1) 32.12 32.38 32.57 32.06 31.07
Support 2 (S2) 31.33 31.98 31.30 30.93
Support 3 (S3) 30.43 31.33 30.79
Support 4 (S4) 30.37